Large animal models for vaccine development and testing

ILAR Journal

Volumn 56, Issue 1, 2015, Pages 53-62

  Gerdts, Volker ^a   Wilson, Heather L ^a   Meurens, Francois ^b   Van den Hurk, Sylvia van Drunen Littel ^a,c   Wilson, Don ^a   Walker, Stewart ^a   Wheler, Colette ^a   Townsend, Hugh ^a   Potter, Andrew A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b LUNAM UNIVERSITÉ   (France)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Animal models; Large animals; Vaccine; Vaccine efficacy

Indexed keywords

ANIMALIA;

VACCINE;

ANIMAL; DISEASE MODEL;

ANIMALS; DISEASE MODELS, ANIMAL; VACCINES;

EID: 84939508666     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilv009     Document Type: Article

References (102)

1. Allen KJ, Rogan D, Finlay BB, Potter AA, Asper DJ. 2011. Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157. Can J Vet Res 75:98-105.
2. An H, Fairbrother JM, Desautels C, Mabrouk T, Dugourd D, Dezfulian H, Harel J. 2000. Presence of the LEE (locus of enterocyte effacement) in pig attaching and effacing Escherichia coli and characterization of eae, espA, espB and espD genes of PEPEC (pig EPEC) strain 1390. Microb Pathog 28:291-300.
3. Antonis AF, Schrijver RS, Daus F, Steverink PJ, Stockhofe N, Hensen EJ, Langedijk JP, van der Most RG. 2003. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. J Virol 77:12067-12073.
4. Azevedo MP, Vlasova AN, Saif LJ. 2013. Human rotavirus viruslike particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev Vaccines 12:169-181.
5. Baldwin CL, Telfer JC. 2015. The bovine model for elucidating the role of γδ T cells in controlling infectious diseases of importance to cattle and humans. Mol Immunol 66:35-47.
6. Barrow PA, Page K, Lovell MA. 2001. The virulence for gnotobiotic pigs of live attenuated vaccine strains of Salmonella enterica serovars Typhimurium and Enteritidis. Vaccine 19:3432-3436.
7. BeanAGD, BakerML, Stewart CR, Cowled C, Deffrasnes C, Wang L-F, Lowenthal JW. 2013. Studying immunity to zoonotic diseases in the natural host-keeping it real. Nat Rev Immunol 13:851-861.
8. Belser JA, Katz JM, Tumpey TM. 2011. The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4:575-579.
9. Billerbeck E, de Jong Y, Dorner M, de la Fuente C, Ploss A. 2013. Animal models for hepatitis C. Curr Top Microbiol Immunol 369:49-86.
10. Billingham RE, Brent L, Medawar PB. 1953. Actively acquired tolerance of foreign cells. Nature 172:603-606.
11. Brandenburg AH, Neijens HJ, Osterhaus AD. 2001. Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. Vaccine 19:2769-2782.
12. Bui T, Kocher J, Li Y, Wen K, Li G, Liu F, Yang X, LeRoith T, Tan M, Xia M, ZhongW, Jiang X, Yuan L. 2013. Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. J Gen Virol 94(Pt 9): 2005-2016.
13. Byrd LG, Prince GA. 1997. Animal models of respiratory syncytial virus infection. Clin Infect Dis 25:1363-1368.
14. Campo MS, Jarrett WF, Barron R, O'Neil BW, Smith KT. 1992. Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. Cancer Res 52:6898-6904.
15. Canadian Council on Animal Care (CCAC). 1998. Guidelines on:choosing an appropriate endpoint in experiments for research, teaching and testing. Introduction, second page, paragraph one.
16. Casadevall A, Imperiale MJ. 2014. Risks and benefits of gain-offunction experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion. MBio 5:e01730-14.
17. Conti F, Abnave P, Ghigo E. 2014. Unconventional animal models:a booster for new advances in host-pathogen interactions. Front Cell Infect Microbiol 4:142.
18. Corbel MJ. 1997. Brucellosis: an overview. Emerg Infect Dis 3:213-221.
19. Dalziel BD, Huang K, Geoghegan JL, Arinaminpathy N, Dubovi EJ, Grenfell BT, Ellner SP, Holmes EC, Parrish CR. 2014. Contact heterogeneity, rather than transmission efficiency, limits the emergence and spread of canine influenza virus. PLoS Pathog 10:e1004455.
20. Dawson H. 2011. A comparative assessment of the pig, mouse, and human genomes: Structural and functional analysis of genes involved in immunity and inflammation. In:McAnulty PA, DayanGanderup ADN-C, Hastings KL, eds. The Minipig in Biomedical Research. Boca Raton, FL, USA: CRC. Press, Taylor & Francis Group. p 664.
21. Dawson HD, Loveland JE, Pascal G, Gilbert JG, Uenishi H, Mann KM, Sang Y, Zhang J, Carvalho-Silva D, Hunt T, Hardy M, Hu Z, Zhao SH, Anselmo A, Shinkai H, Chen C, Badaoui B, Berman D, Amid C, Kay M, Lloyd D, Snow C, Morozumi T, Cheng RP, Bystrom M, Kapetanovic R, Schwartz JC, Kataria R, Astley M, Fritz E, Steward C, Thomas M, Wilming L, Toki D, Archibald AL, Bed'Hom B, Beraldi D, Huang TH, Ait-Ali T, Blecha F, Botti S, Freeman TC, Giuffra E, Hume DA, Lunney JK, Murtaugh MP, Reecy JM, Harrow JL, Rogel-Gaillard C, Tuggle CK. 2013. Structural and functional annotation of the porcine immunome. BMC Genomics 14:332.
22. De Bont J, Vercruysse J, Grzych JM, Meeus PF, Capron A. 1997. Potential of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental and natural S. mattheei infection. Parasitology 115(Pt 3): 249-255.
23. Derscheid RJ, Gallup JM, Knudson CJ, Varga SM, Grosz DD, van Geelen A, Hostetter SJ, Ackermann MR. 2013. Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV. PLoS One 8:e81472.
24. Derscheid RJ, van Geelen A, Gallup JM, Kienzle T, Shelly DA, Cihlar T, King RR, Ackermann MR. 2014. Human respiratory syncytial virus memphis 37 causes acute respiratory disease in perinatal lamb lung. Biores Open Access 3:60-69.
25. de Veer M, Kemp J, Chatelier J, Elhay MJ, Meeusen EN. 2010. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine 28:6597-6602.
26. Dyce KM, Sack WO, Wensing CJ. 1987. Textbook of Veterinary Anatomy. Philadelphia, PA: WB Saunders.
27. Elahi S, Brownlie R, Korzeniowski J, Buchanan R, O'Connor B, Peppler MS, Halperin SA, Lee SF, Babiuk LA, Gerdts V. 2005. Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun 73:3636-3645.
28. Elahi S, Buchanan RM, Attah-Poku S, Townsend HG, Babiuk LA, Gerdts V. 2006. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect Immun 74:2338-2352.
29. Elahi S, Buchanan RM, Babiuk LA, Gerdts V. 2006. Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun 74:2619-2627.
30. Elahi S, Holmstrom J, Gerdts V. 2007. The benefits of using diverse animal models for studying pertussis. Trends Microbiol 15:462-468.
31. Elahi S, Thompson DR, Strom S, O'Connor B, Babiuk LA, Gerdts V. 2008. Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs. J Infect Dis 198:384-392.
32. Ellis J, Gow S, West K, Waldner C, Rhodes C, Mutwiri G, Rosenberg H. 2007. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. J Am Vet Med Assoc 230:233-243.
33. Endsley JJ, Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, Jacobs WR Jr, Larsen MH, Hogg A, Shell E, McAlauy M, Scherer CF, Coffey T, Howard CJ, Villareal-Ramos B, Estes DM. 2009. The calf model of immunity for development of a vaccine against tuberculosis. Vet Immunol Immunopathol 128:199-204.
34. Gerdts V, Babiuk LA, van Drunen Littel-van den H, Griebel PJ. 2000. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat Med 6:929-932.
35. Gerdts V, Snider M, Brownlie R, Babiuk LA, Griebel PJ. 2002. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J Immunol 168:1877-1885.
36. Gerdts V, Uwiera RR, Mutwiri GK, Wilson DJ, Bowersock T, Kidane A, Babiuk LA, Griebel PJ. 2001. Multiple intestinal 'loops' provide an in vivo model to analyse multiple mucosal immune responses. J Immunol Methods 256:19-33.
37. Gonzalez AM, Azevedo MS, Jung K, Vlasova A, Zhang W, Saif LJ. 2010. Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model. Immunology 131:242-256.
38. GrahamJP, Leibler JH, Price LB, Otte JM, Pfeiffer DU, Tiensin T, Silbergeld EK. 2008. The animal-human interface and infectious disease in industrial food animal production: rethinking biosecurity and biocontainment. Public Health Rep 123:282-299.
39. Griebel PJ, Hein WR. 1996. Expanding the role of Peyer's patches in B-cell ontogeny. Immunol Today 17:30-39.
40. Hein WR, Griebel PJ. 2003. A road less travelled: large animal models in immunological research. Nat Rev Immunol 3:79-84.
41. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541.
42. Hokey DA, Ginsberg A. 2013. The current state of tuberculosis vaccines. Hum Vaccin Immunother 9:2142-2146.
43. Hope JC, Thom ML, Villarreal-Ramos B, Vordermeier HM, Hewinson RG, Howard CJ. 2005. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin Exp Immunol 139:48-56.
44. Horohov DW. 2015. The equine immune responses to infectious and allergic disease: A model for humans? Mol Immunol 66:89-96.
45. Horter DC, Yoon KJ, Zimmerman JJ. 2003. A review of porcine tonsils in immunity and disease. Anim Health Res Rev 4:143-155.
46. Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, Kapikian AZ. 1995. Identification of group Arotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology 209:274-280.
47. Husband AJ. 1980. Intestinal immunity following a single intraperitoneal immunisation in lambs. Vet Immunol Immunopathol 1:277-286.
48. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428.
49. Jeong KI, Zhang Q, Nunnari J, Tzipori S. 2010. A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1. J Infect Dis 201:903-911.
50. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. 2008. Global trends in emerging infectious diseases. Nature 451:990-993.
51. Kawashima K, Meyerholz DK, Gallup JM, Grubor B, Lazic T, Lehmkuhl HD, Ackermann MR. 2006. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol 19:316-323.
52. Keggan A, Freer H, Rollins A, Wagner B. 2013. Production of seven monoclonal equine immunoglobulins isotyped by multiplex analysis. Vet Immunol Immunopathol 153:187-193.
53. Ko J, Splitter GA. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 16:65-78.
54. Kuiken T, Rimmelzwaan G, van Riel D, van Amerongen G, Baars M, Fouchier R, Osterhaus A. 2004. Avian H5N1 influenza in cats. Science 306:241.
55. Lager KM, Vincent AL. 2014. In vivo models for pathotyping and vaccine efficacy for swine influenza. Methods Mol Biol 1161:355-361.
56. LeBlanc PH, Baker JC, Gray PR, Robinson NE, Derksen FJ. 1991. Effects of bovine respiratory syncytial virus on airway function in neonatal calves. Am J Vet Res 52:1401-1406.
57. Lefevre EA, Carr BV, Inman CF, Prentice H, Brown IH, Brookes SM, Garcon F, Hill ML, Iqbal M, Elderfield RA, Barclay WS, Gubbins S, Bailey M, Charleston B, 2012. Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A (H1N1)pdm/09 influenza vaccines used in human immunization programmes. PLoS One 7:e32400.
58. Liang TJ. 2013. Current progress in development of hepatitis C virus vaccines. Nat Med 19:869-878.
59. Mair KH, Sedlak C, Kaser T, Pasternak A, Levast B, Gerner W, Saalmuller A, Summerfield A, Gerdts V, Wilson HL, Meurens F. 2014. The porcine innate immune system: an update. Dev Comp Immunol 45:321-343.
60. Mapletoft JW, Oumouna M, Townsend HG, Gomis S, Babiuk LA, van Drunen Littel-van den Hurk S. 2006. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalininactivated bovine respiratory syncytial virus. Virology 353:316-323.
61. Margine I, Krammer F. 2014. Animal models for influenza viruses:implications for universal vaccine development. Pathogens 3:845-874.
62. McLaughlin RF, Tyler WS, Canada RO. 1961. A study of the subgross pulmonary anatomy of various mammals. Am J Anat 108:149-165.
63. McShane H, Williams A. 2014. A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis (Edinb) 94:105-110.
64. Meeusen EN. 2011. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 29:8506-8511.
65. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. 2012. The pig: a model for human infectious diseases. Trends Microbiol 20:50-57.
66. Meyer G, Deplanche M, Schelcher F. 2008. Human and bovine respiratory syncytial virus vaccine research and development. Comp Immunol Microbiol Infect Dis 31:191-225.
67. Meyerholz DK, Grubor B, Fach SJ, Sacco RE, Lehmkuhl HD, Gallup JM, Ackermann MR. 2004. Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect 6:1312-1319.
68. Mills KHG, Gerdts V. 2014. Mouse and Pig Models for Studies of Natural and Vaccine-Induced Immunity to Bordetella pertussis. Journal of Infectious Diseases 209(suppl 1):S16-S19.
69. Munday JS. 2014. Bovine and Human Papillomaviruses: A Comparative Review. Veterinary Pathology 51:1063-1075.
70. Mutwiri G, Bateman C, Baca-Estrada ME, Snider M, Griebel P. 2000. Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. Vaccine 19:1284-1293.
71. Olivier A, Gallup J, deMacedo MM, Varga SM, Ackermann M. 2009. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int J Exp Pathol 90:431-438.
72. Openshaw PJ, Tregoning JS. 2005. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 18:541-555.
73. Oreshkova N, van Keulen L, Kant J, Moormann RJ, Kortekaas J. 2013. A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. PLoS One 8:e77461.
74. Patz JA, Daszak P, Tabor GM, Aguirre AA, Pearl M, Epstein J, Wolfe ND, Kilpatrick AM, Foufopoulos J, Molyneux D. 2004. Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. Environ Health Perspect 112:1092-1098.
75. Polewicz M, Gracia A, Garlapati S, van Kessel J, Strom S, Halperin SA, Hancock RE, Potter AA, Babiuk LA, Gerdts V. 2013. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine 31:3148-3155.
76. Potter AA, Klashinsky S, Li Y, Frey E, Townsend H, Rogan D, Erickson G, Hinkley S, Klopfenstein T, Moxley RA, Smith DR, Finlay BB. 2004. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 22:362-369.
77. Pravieux JJ, Poulet H, Charreyre C, Juillard V. 2007. Protection of newborn animals through maternal immunization. J Comp Pathol 137(Suppl 1):S32-S34.
78. Probert M, Stott EJ, Thomas LH, Collins AP, Jebbett J. 1978. An inactivated parainfluenza virus type 3 vaccine: the influence of vaccination regime on the response of calves and their subsequent resistance to challenge. Res Vet Sci 24:222-227.
79. Pulliam JR, Epstein JH, Dushoff J, Rahman SA, Bunning M, Jamaluddin AA, Hyatt AD, Field HE, Dobson AP, Daszak P. 2012. Agricultural intensification, priming for persistence and the emergence of Nipah virus: a lethal bat-borne zoonosis. J R Soc Interface 9:89-101.
80. Rehli M. 2002. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol 23:375-378.
81. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB, Zabner J, Prather RS, Welsh MJ. 2008. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321:1837-1841.
82. Sachs DH. 1994. The pig as a potential xenograft donor. Vet Immunol Immunopathol 43:185-191.
83. Sachs DH, Leight G, Cone J, Schwarz S, Stuart L, Rosenberg S. 1976. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 22:559-567.
84. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lapez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110:3507-3512.
85. Siddiqui N, Price S, Hope J. 2012. BCG vaccination of neonatal calves: potential roles for innate immune cells in the induction of protective immunity. Comp Immunol Microbiol Infect Dis 35:219-226.
86. Sow FB, Gallup JM, Olivier A, Krishnan S, Patera AC, Suzich J, Ackermann MR. 2011. Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol Physiol 300:L12-L24.
87. Steele J, Feng H, Parry N, Tzipori S. 2010. Piglet models of acute or chronic Clostridium difficile illness. J Infect Dis 201:428-434.
88. Summerfield A, Meurens F, Ricklin ME. 2015. The immunology of the porcine skin and its value as a model for human skin. Mol Immunol 66:14-21.
89. Swindle MM, Makin A, Herron AJ, Clubb FJ Jr., Frazier KS. 2012. Swine as models in biomedical research and toxicology testing. Vet Pathol 49:344-356.
90. Taylor G. 2013. Bovine model of respiratory syncytial virus infection. Curr Top Microbiol Immunol 372:327-345.
91. Tzipori SR, Makin TJ, Smith ML. 1980. The clinical response of gnotobiotic calves, pigs and lambs to inoculation with human, calf, pig and foal rotavirus isolates. Aust J Exp Biol Med Sci 58:309-318.
92. Van Den Ingh TS, Verhoeff J, Van Nieuwstadt AP. 1982. Clinical and pathological observations on spontaneous bovine respiratory syncytial virus infections in calves. Res Vet Sci 33:152-158.
93. Vanrompay D, Hoang TQ, De Vos L, Verminnen K, Harkinezhad T, Chiers K, Morre SA, Cox E. 2005. Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection. Infect Immun 73:8317-8321.
94. Vaure C, Liu Y. 2014. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol 5:316.
95. Vergara-Alert J, Argilaguet JM, Busquets N, Ballester M, Martin-Valls GE, Rivas R, Lopez-Soria S, Solanes D, Majo N, Segales J, Veljkovic V, Rodraguez F, Darji A. 2012. Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model. PLoS One 7:e40524.
96. Vujanic A, Snibson KJ, Wee JL, Edwards SJ, Pearse MJ, Scheerlinck JP, Sutton P. 2012. Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine. Clin Vaccine Immunol 19:79-83.
97. Vujanic A, Wee JL, Snibson KJ, Edwards S, Pearse M, Quinn C, MoloneyM, Taylor S, Scheerlinck JP, Sutton P. 2010. Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX adjuvanted recombinant antigens. Vaccine 28:2593-2597.
98. Waters WR, Palmer MV, Thacker TC, Davis WC, Sreevatsan S, Coussens P, Meade KG, Hope JC, Estes DM. 2011. Tuberculosis immunity: opportunities from studies with cattle. Clin Dev Immunol 2011:768542.
99. Webb JC, Mergler D, Parkes MW, Saint-Charles J, Spiegel J, Waltner-Toews D, Yassi A, Woollard RF. 2010. Tools for thoughtful action: the role of ecosystem approaches to health in enhancing public health. Can J Public Health 101:439-441.
100. Yekta MA, Goddeeris BM, Vanrompay D, Cox E. 2011. Immunization of sheep with a combination of intimingamma, EspA and EspB decreases Escherichia coli O157:H7 shedding. Vet Immunol Immunopathol 140:42-46.
101. Yen HH, Wee JL, Snibson KJ, Scheerlinck JP. 2009. Thoracic duct cannulation without thoracotomy in sheep: a method for accessing efferent lymph from the lung. Vet Immunol Immunopathol 129:76-81.
102. Yuan L, Saif LJ. 2002. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet Immunol and Immunopath 87:147-160.